Tag Archives: Survival
Another Option in the Second Line Treatment of Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
Docetaxel(Taxotere) has long been considered the standard of care for second-line treatment of advanced NSCLC. However, the disadvantage of using this agent include the need to administer it with corticosteroid premedication and its toxicity profile A new study published in … Continue reading
Pancreatic cancer – Causes, Prevention, Prognosis, Diagnosis and Latest Treatment
Prevalence Pancreatic cancer is the fourth most common cause of adult cancer death, accounting for an estimated 42,470 new cases and 35,240 deaths in USA for 2009. The high mortality rate is due to the high incidence of metastatic disease … Continue reading
Gefitinib Improves Progression-Free Survival in Metastatic Breast Cancer
According to a new study published in the Clinical Cancer Research, adding epidermal growth factor receptor (EGFR) inhibitor gefitinib (Iressa) to anastrozole (Arimidex) improved progression-free survival in postmenopausal women with hormone receptor-positive metastatic breast cancer. The study randomized 93 postmenopausal … Continue reading
New Standard Treatment for Advanced Biliary Tract Cancer: Cisplatin Plus Gemcitabine
Good news for patients with advanced biliary tract cancer. Combination of cisplatin and gemcitabine (Gemzar) have been shown to be an effective treatment option for patients with locally advanced or metastatic biliary tract cancer. In developed nations, biliary tract cancer … Continue reading
Taking Aspirin Can Also Improve Survival after Breast Cancer
Previously, we have the beneficial effect of Aspirin in reducing in the death among colorectal cancer patients. Now, a prospective, observational study published in the March issue of the Journal of Clinical Oncology suggested that aspirin can also lower the … Continue reading
Alternative 1st Treatment for Small-Cell Lung Cancer Patients with Extensive Disease
Lung cancer is the most common diagnosed cancer worldwide and small-cell lung cancer (SCLC) accounts for only 10%-15% of lung cancer cases. Etoposide in combination with cisplatin (EP) or carboplatin is currently considered the standard of care in most countries, but … Continue reading
Best Regimen Sequence for Early Breast Cancer patients
Which is the best chemotherapy adjuvant regimen sequence for early breast cancer? It is widely known that anthracyclines (epirubicin and doxorubicin) and taxanes is the best adjuvant chemotherapy regimen for early breast cancer. However, should anthracyclines be always administered before taxanes? An article published … Continue reading
Alternative Treatment Options for Late Stage Lung Cancer Patients
Paclitaxel plus carboplatin(PC) is the current standard regimen for advanced or metastatic non-small-cell lung cancer (NSCLC) patients. However, paclitaxel is associated with serious toxicity such as peripheral neuropathy. A tria,l published in October version of the Annals of Oncology, was … Continue reading
New Drug Offer Hope to Patients with Late Stage Prostate Cancer
At present, metastatic and hormonal-refractory prostate cancer patients who have failed 1st line chemotherapy will be given mitoxantrone plus prednisone as the salvage therapy. However, mitoxantrone plus prednisone is not very effective in controlling metastatic prostate cancer. Now, a new … Continue reading